209 related articles for article (PubMed ID: 7239521)
41. One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.
Valerio D; Dekker BM; Duyvesteyn MG; van der Voorn L; Berkvens TM; van Ormondt H; van der Eb AJ
EMBO J; 1986 Jan; 5(1):113-9. PubMed ID: 3007108
[TBL] [Abstract][Full Text] [Related]
42. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
Sawami H; Ito K; Norioka M; Monden S; Fujita M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
[TBL] [Abstract][Full Text] [Related]
43. [Genetic and epigenetic control of adenosine deaminase expression. Analysis of human and man-mouse hybrid cells (author's transl)].
Nguyen VC; Weil D; Gross MS; Foubert C; Jami J; Frézal J
Ann Genet; 1981; 24(3):141-7. PubMed ID: 6974523
[TBL] [Abstract][Full Text] [Related]
44. Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency.
Hirschhorn R; Vawter GF; Kirkpatrick JA; Rosen FS
Clin Immunol Immunopathol; 1979 Sep; 14(1):107-20. PubMed ID: 477037
[No Abstract] [Full Text] [Related]
45. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
46. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
[TBL] [Abstract][Full Text] [Related]
47. Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
Perignon JL; Hamet M; Cartier P; Griscelli C
Adv Exp Med Biol; 1980; 122A():403-8. PubMed ID: 6968500
[No Abstract] [Full Text] [Related]
48. A new approach to detection of heterozygotes for adenosine deaminase deficiency: a hypothetical method.
Sakura N; Usui T; Ito K; Ha KS; Ikeda T; Yabuuchi H; Iwanami N; Komiyama A; Akabane T
Eur J Pediatr; 1981 Oct; 137(2):207-10. PubMed ID: 7308233
[TBL] [Abstract][Full Text] [Related]
49. A family of adenosine deaminase deficiency with severe combined immunodeficiency.
Tsuchiya S; Narisawa K; Konno T; Tada K
Jinrui Idengaku Zasshi; 1979 Jun; 24(2):95-8. PubMed ID: 529554
[No Abstract] [Full Text] [Related]
50. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
[TBL] [Abstract][Full Text] [Related]
51. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
Bonthron DT; Markham AF; Ginsburg D; Orkin SH
J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
[TBL] [Abstract][Full Text] [Related]
52. Adenosine deaminase deficiency: another family with "silent" ADA allele and normal ADA activity in two heterozygotes.
Chen SH; Scott CR; Giblett ER; Levin AS
Am J Hum Genet; 1977 Nov; 29(6):642-4. PubMed ID: 930931
[No Abstract] [Full Text] [Related]
53. Expression of human adenosine deaminase after fusion of adenosine deaminase-deficient cells with mouse fibroblasts.
Siciliano MJ; Bordelon MR; Kohler PO
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):936-40. PubMed ID: 273255
[TBL] [Abstract][Full Text] [Related]
54. Genetic heterogeneity in partial adenosine deaminase deficiency.
Hirschhorn R; Martiniuk F; Roegner-Maniscalco V; Ellenbogen A; Perignon JL; Jenkins T
J Clin Invest; 1983 Jun; 71(6):1887-92. PubMed ID: 6863546
[TBL] [Abstract][Full Text] [Related]
55. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
Tsuchiya S; Narisawa K; Konno T; Tada K
Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
[TBL] [Abstract][Full Text] [Related]
56. Investigation of the intrachromosomal position of the ADA locus on chromosome 20 by gene dosage studies.
Aitken DA; Ferguson-Smith MA
Cytogenet Cell Genet; 1978; 22(1-6):514-7. PubMed ID: 752533
[No Abstract] [Full Text] [Related]
57. Localization of human adenosine deaminase (ADA) gene sequences to the q12----q13.11 region of chromosome 20 by in situ hybridization.
Jhanwar SC; Berkvens TM; Breukel C; van Ormondt H; van der Eb AJ; Meera Khan P
Cytogenet Cell Genet; 1989; 50(2-3):168-71. PubMed ID: 2776485
[TBL] [Abstract][Full Text] [Related]
58. Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID).
Hirschhorn R; Chakravarti V; Puck J; Douglas SD
Am J Hum Genet; 1991 Oct; 49(4):878-85. PubMed ID: 1680289
[TBL] [Abstract][Full Text] [Related]
59. Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.
Ziegler JB; Lee CH; Van der Weyden MB; Bagnara AS; Beveridge J
Arch Dis Child; 1980 Jun; 55(6):452-7. PubMed ID: 7436484
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of one of two adenosine deaminase alleles in a human choriocarcinoma cell line following selection with adenine nucleosides.
Yeung CY; Riser ME; Kellems RE; Siciliano MJ
J Biol Chem; 1983 Jul; 258(13):8330-7. PubMed ID: 6683274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
